Medscape Medical News. FDA Advisory Panel Urges Restrictions on Testosterone Use. Medscape Family Medicine. Available at www.medscape.com/viewarticle/831897 Last accessed October2, 2014.
2.
BhasinS, CunninghamGR, HayesFJ, et al.Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2010; 95:2536–2539.
RossouwJE, AndersonGL, PrenticeRL, et al.Writing Group for the Women's Health Initiative Invesigators. Risks and benefits of estrogen plus progestin in health postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 2002; 288:321–333.
5.
MulliganT, FrickMF, ZurawQC, et al.Prevalence of hypogonadism in males aged at least 45 years: The HIM study. Int J Clin Pract, 2006; 60:762–769.
6.
ShoresMM, SmithNL, ForsbergCW, et al.Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab, 2012; 97:2050–2058.
7.
ShoresMM, MatsumotoAM, SloanKL, et al.Low serum testosterone and mortality in male veterans. Arch Intern Med, 2006; 166:1660–1665.
8.
VigenR, O'DonnellCI, BaronAE, et al.Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA, 2013; 310:1829–1836.
9.
FinkleWD, GreenlandS, RidgewayGK, et al.Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One, 2014; 9:e85805.
10.
BasariaS, CovielloAD, TravisonTG, et al.Adverse events associated with testosterone administration. N Engl J Med, 2010; 363:109–122.
11.
GrechA, BreckJ, HeidelbaughJJ. Adverse effects of testosterone replacement therapy: An update on the evidence and controversy. Ther Adv Drug Safety, 2014; 5:190–200.
